Capital Research Global Investors Biomarin Pharmaceutical Inc Transaction History

Capital Research Global Investors

  • $440 Billion
  • Q1 2025

A detailed history of Capital Research Global Investors transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Capital Research Global Investors holds 9,150,655 shares of BMRN stock, worth $535 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
9,150,655
Previous 12,991,772 29.57%
Holding current value
$535 Million
Previous $854 Million 24.25%
% of portfolio
0.15%
Previous 0.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$61.25 - $72.83 $235 Million - $280 Million
-3,841,117 Reduced 29.57%
9,150,655 $647 Million
Q4 2024

Feb 13, 2025
BUY
$61.93 - $70.49 $155 Million - $176 Million
2,496,817 Added 23.79%
12,991,772 $854 Million
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $55.4 Million - $75.3 Million
802,389 Added 8.28%
10,494,955 $738 Million
Q2 2024

Aug 13, 2024
BUY
$74.43 - $92.22 $236 Million - $293 Million
3,171,905 Added 48.64%
9,692,566 $798 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $357 Million - $421 Million
-4,253,980 Reduced 39.48%
6,520,661 $570 Million
Q4 2023

Feb 13, 2024
BUY
$76.22 - $98.51 $363 Million - $469 Million
4,756,671 Added 79.04%
10,774,641 $1.04 Billion
Q3 2023

Nov 13, 2023
SELL
$85.07 - $94.48 $62.8 Million - $69.7 Million
-738,062 Reduced 10.92%
6,017,970 $532 Million
Q2 2023

Aug 11, 2023
SELL
$86.68 - $100.3 $39.3 Million - $45.4 Million
-452,927 Reduced 6.28%
6,756,032 $586 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $137 Million - $183 Million
1,557,958 Added 27.57%
7,208,959 $701 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $57.8 Million - $77.6 Million
714,261 Added 14.47%
5,651,001 $585 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $114,531 - $135,134
1,394 Added 0.03%
4,936,740 $418 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $318 Million - $387 Million
-4,452,610 Reduced 47.43%
4,935,346 $409 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $244 Million - $304 Million
-3,284,052 Reduced 25.92%
9,387,956 $724 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $357 Million - $455 Million
-4,973,431 Reduced 28.19%
12,672,008 $1.12 Billion
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $332 Million - $380 Million
-4,440,950 Reduced 20.11%
17,645,439 $1.36 Billion
Q2 2021

Aug 16, 2021
BUY
$75.51 - $84.79 $756,912 - $849,934
10,024 Added 0.05%
22,086,389 $1.84 Billion
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $193,700 - $235,068
-2,592 Reduced 0.01%
22,076,365 $1.67 Billion
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $1.14 Million - $1.42 Million
15,695 Added 0.07%
22,078,957 $1.94 Billion
Q3 2020

Nov 13, 2020
SELL
$71.87 - $131.03 $180,681 - $329,409
-2,514 Reduced 0.01%
22,063,262 $1.68 Billion
Q2 2020

Aug 14, 2020
BUY
$79.55 - $124.22 $2 Million - $3.13 Million
25,158 Added 0.11%
22,065,776 $2.72 Billion
Q1 2020

May 15, 2020
BUY
$71.37 - $96.85 $2.61 Million - $3.54 Million
36,553 Added 0.17%
22,040,618 $1.86 Billion
Q4 2019

Feb 18, 2020
BUY
$64.27 - $86.37 $19 Million - $25.6 Million
296,401 Added 1.37%
22,004,065 $1.86 Billion
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $136 Million - $171 Million
2,011,459 Added 10.21%
21,707,664 $1.46 Billion
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $156 Million - $183 Million
1,947,144 Added 10.97%
19,696,205 $1.69 Billion
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $46.7 Million - $54.7 Million
-555,102 Reduced 3.03%
17,749,061 $1.58 Billion
Q4 2018

Feb 14, 2019
SELL
$80.14 - $106.07 $99.8 Million - $132 Million
-1,244,970 Reduced 6.37%
18,304,163 $1.56 Billion
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $192 Million - $216 Million
-2,043,999 Reduced 9.47%
19,549,133 $1.9 Billion
Q2 2018

Aug 14, 2018
BUY
$76.01 - $99.03 $7.01 Million - $9.14 Million
92,281 Added 0.43%
21,593,132 $2.03 Billion
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $621 - $741
-8 Reduced -0.0%
21,500,851 $1.74 Billion
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $52.5 Million - $61.9 Million
650,258 Added 3.12%
21,500,859 $1.92 Billion
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $1.68 Billion - $1.98 Billion
20,850,601
20,850,601 $1.94 Billion

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
184M
Call Options Held
1.24M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email